FR2864541B1 - Anticorps anti-inhibiteur de l'uracile-adn-glycosylase et leurs applications pour la decontamination des reactions d'amplification des acides nucleiques - Google Patents

Anticorps anti-inhibiteur de l'uracile-adn-glycosylase et leurs applications pour la decontamination des reactions d'amplification des acides nucleiques

Info

Publication number
FR2864541B1
FR2864541B1 FR0315625A FR0315625A FR2864541B1 FR 2864541 B1 FR2864541 B1 FR 2864541B1 FR 0315625 A FR0315625 A FR 0315625A FR 0315625 A FR0315625 A FR 0315625A FR 2864541 B1 FR2864541 B1 FR 2864541B1
Authority
FR
France
Prior art keywords
glycosylase
decontamination
uracil
dna
applications
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR0315625A
Other languages
English (en)
Other versions
FR2864541A1 (fr
Inventor
Alphonse Calenda
Bernard Montanari
Bruno Montanari
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
KABERTEX
Original Assignee
KABERTEX
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by KABERTEX filed Critical KABERTEX
Priority to FR0315625A priority Critical patent/FR2864541B1/fr
Priority to US10/596,965 priority patent/US20090170166A1/en
Priority to PCT/FR2004/003336 priority patent/WO2005073253A1/fr
Priority to EP04816465A priority patent/EP1699827A1/fr
Publication of FR2864541A1 publication Critical patent/FR2864541A1/fr
Application granted granted Critical
Publication of FR2864541B1 publication Critical patent/FR2864541B1/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6844—Nucleic acid amplification reactions
    • C12Q1/6848—Nucleic acid amplification reactions characterised by the means for preventing contamination or increasing the specificity or sensitivity of an amplification reaction
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/081—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from DNA viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
    • C07K2317/76—Antagonist effect on antigen, e.g. neutralization or inhibition of binding

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
FR0315625A 2003-12-31 2003-12-31 Anticorps anti-inhibiteur de l'uracile-adn-glycosylase et leurs applications pour la decontamination des reactions d'amplification des acides nucleiques Expired - Fee Related FR2864541B1 (fr)

Priority Applications (4)

Application Number Priority Date Filing Date Title
FR0315625A FR2864541B1 (fr) 2003-12-31 2003-12-31 Anticorps anti-inhibiteur de l'uracile-adn-glycosylase et leurs applications pour la decontamination des reactions d'amplification des acides nucleiques
US10/596,965 US20090170166A1 (en) 2003-12-31 2004-12-22 Antibody inhibiting uracil-dna-glycosylase and uses thereof for decontaminating nucleic acid amplification reactions
PCT/FR2004/003336 WO2005073253A1 (fr) 2003-12-31 2004-12-22 Anticorps anti-inhibiteur de l'uracile-adn-glycosylase et leurs applications pour la decontamination des reactions d'amplification des acides nucleiques
EP04816465A EP1699827A1 (fr) 2003-12-31 2004-12-22 Anticorps anti-inhibiteur de l'uracile-adn-glycosylase et leurs applications pour la decontamination des reactions d'amplfication des acides nucleiques

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0315625A FR2864541B1 (fr) 2003-12-31 2003-12-31 Anticorps anti-inhibiteur de l'uracile-adn-glycosylase et leurs applications pour la decontamination des reactions d'amplification des acides nucleiques

Publications (2)

Publication Number Publication Date
FR2864541A1 FR2864541A1 (fr) 2005-07-01
FR2864541B1 true FR2864541B1 (fr) 2006-03-10

Family

ID=34639734

Family Applications (1)

Application Number Title Priority Date Filing Date
FR0315625A Expired - Fee Related FR2864541B1 (fr) 2003-12-31 2003-12-31 Anticorps anti-inhibiteur de l'uracile-adn-glycosylase et leurs applications pour la decontamination des reactions d'amplification des acides nucleiques

Country Status (4)

Country Link
US (1) US20090170166A1 (fr)
EP (1) EP1699827A1 (fr)
FR (1) FR2864541B1 (fr)
WO (1) WO2005073253A1 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109609495B (zh) * 2018-12-31 2023-05-23 苏州近岸蛋白质科技股份有限公司 一种高纯度单链dna制备方法及其应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2122203C (fr) * 1993-05-11 2001-12-18 Melinda S. Fraiser Decontamination des reactions d'amplification d'acides nucleiques
DE19736062A1 (de) * 1997-08-20 1999-02-25 Boehringer Mannheim Gmbh Reduktion von Kreuzkontaminationen bei Nukleinsäureamplifikationen

Also Published As

Publication number Publication date
US20090170166A1 (en) 2009-07-02
EP1699827A1 (fr) 2006-09-13
WO2005073253A1 (fr) 2005-08-11
FR2864541A1 (fr) 2005-07-01

Similar Documents

Publication Publication Date Title
AU7878301A (en) Method of amplifying nucleic acid
FR2834295B1 (fr) Cristaux de glucokinase et leurs methodes de culture
GB0118959D0 (en) Nucleic acid amplification method
AU2002365912A8 (en) Pyrophosphorolysis and incorporation of nucleotide method for nucleic acid detection
AU2003280603A8 (en) Method of amplifying nucleic acid
FI20040668A (fi) Platinaryhmän metalleja sisältävien malmimateriaalien valmistus
ITMI20050353A1 (it) Sistema di interoperabilita' di applicazioni eseguibili e creazione di interfaccia
ITRM20040438A1 (it) Metodo per la purificazione e l'amplificazione di cellule staminali tumorali.
HK1092175A1 (en) Nucleic acid amplifier and method of nucleic acid amplification
NO20032822L (no) Fremgangsmate for konsentrering av brukt syre
NO20024926D0 (no) Materialer og fremgangsmåter for den biologiske produksjon av svovelsyre
GB0314840D0 (en) Genetic analysis of microorganisms
DK1456404T3 (da) Fremgangsmåde til at bestemme difibrotids biologiske aktivitet
FR2864541B1 (fr) Anticorps anti-inhibiteur de l'uracile-adn-glycosylase et leurs applications pour la decontamination des reactions d'amplification des acides nucleiques
NO20043400L (no) Fremgangsmater for nukleinsyreamplifisering
DZ3174A1 (fr) Composition catalytique et procédé utilisant cettecomposition.
NO20041763L (no) Regulert nukleinsyreekspresjonssystem
DE60007547D1 (de) 15-hydroxyeicosatetraensäure verwandte verbindungen und anwendungsverfahren
AU2003272189A1 (en) Caspase inhibitors for the treatment of diseases and conditions caused by exposure to radionuclides, biological agents, or chemical agents
AU2002366435A8 (en) Nucleic acid amplification
FR2822846B1 (fr) Procede de preparation et de selection d'anticorps
FR2821080B1 (fr) Anticorps specifique de l'adrenomedulline humaine, composition pharmaceutique le contenant, ses applications therapeutiques
EP1420068A4 (fr) Methode d'analyse d'acide nucleique specifiant un gene presentant un changement de dose d'expression en schizophrenie
NO20033779L (no) Fremgangsmåte for biologisk rensing av avlöpsvann ved anvendelse av biofilmbårede partikler
EP1461427A4 (fr) Procedes d'expression ciblee d'un acide nucleique therapeutique

Legal Events

Date Code Title Description
TP Transmission of property
ST Notification of lapse

Effective date: 20100831